IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with lower-intensity therapy Meeting Abstract
| Authors: | Hoff, F. W.; Huang, Y.; Li Welkie, R.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Patel, P. A.; Collins, R. H.; Baer, M. R.; Duong, V. H.; Blum, W.; Arellano, M. L.; Stock, W.; Odenike, O.; Redner, R. L.; Kovacsovics, T. J.; Deininger, M. W.; Zeidner, J. F.; Olin, R.; Smith, C. C.; Foran, J. M.; Schiller, G. J.; Curran, E. K.; Koenig, K. L.; Heerema, N. A.; Chen, T. M.; Martycz, M.; Stefanos, M.; Marcus, S. G.; Rosenberg, L.; Druker, B. J.; Levine, R. L.; Burd, A.; Yocum, A. O.; Borate, U.; Mims, A.; Byrd, J. C.; Madanat, Y. F. |
| Abstract Title: | IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with lower-intensity therapy |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-06 |
| Start Page: | 4326 |
| End Page: | 4327 |
| Language: | English |
| ACCESSION: | WOS:001412802400010 |
| DOI: | 10.1182/blood-2024-202596 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
